Therefore, the IGF-1R signaling pathway and its downstream cell survival mediator XIAP may be potential dual targets for anticancer therapy
Therefore, the IGF-1R signaling pathway and its downstream cell survival mediator XIAP may be potential dual targets for anticancer therapy. In conclusion, this study demonstrated… Read More »Therefore, the IGF-1R signaling pathway and its downstream cell survival mediator XIAP may be potential dual targets for anticancer therapy